We are live on
!
Find out more
SA
Strategic Advisors Portfolio holdings
AUM
$602M
1-Year Est. Return
21.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.72%
1 Year Est. Return
+21.41%
3 Year Est. Return
+78.51%
5 Year Est. Return
+103.22%
10 Year Est. Return
+357.04%
AUM
$173M
AUM Growth
-$2.43M
(-1.4%)
Cap. Flow
-$4.72M
Cap. Flow
% of AUM
-2.73%
Top 10 Holdings %
Top 10 Hldgs %
29.89%
Holding
135
New
6
Increased
55
Reduced
48
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
|
+$1.35M |
| 2 |
Weyerhaeuser
WY
|
+$1.23M |
| 3 |
Truist Financial
TFC
|
+$1.18M |
| 4 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$792K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$722K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$2.08M |
| 2 |
WRI
Weingarten Realty Investors
WRI
|
+$1.69M |
| 3 |
Pfizer
PFE
|
+$1.26M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$932K |
| 5 |
Citigroup
C
|
+$748K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.91% |
| 2 | Healthcare | 13.12% |
| 3 | Industrials | 13.01% |
| 4 | Communication Services | 9.93% |
| 5 | Consumer Staples | 8.61% |
Similar funds
ERWM
IECM
CIG
PIFP
NPCM
OCAM
CTA
CNBTD
Strategic Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, Strategic Advisors held 135 positions worth $173M, down 1.4% from $176M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Strategic Advisors's Q2 2016 filing shows 6 new, 55 increased, 48 reduced and 19 closed positions. Its largest new stake was Nuveen New York AMT-Free Quality Municipal Income Fund: 97,169 shares worth $1.39M. The largest sale was GSK, an estimated $2.08M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.
- Strategic Advisors's largest Q2 2016 buy was Nuveen New York AMT-Free Quality Municipal Income Fund: 97,169 shares worth $1.39M.
- Strategic Advisors added most to Invesco S&P 500 Low Volatility ETF in Q2 2016, an estimated $792K increase.
- Strategic Advisors's biggest Q2 2016 reduction was Pfizer, cutting an estimated $1.26M.
- Strategic Advisors fully exited GSK in Q2 2016, selling an estimated $2.08M.
- Strategic Advisors's ten largest holdings make up 30% of its $173M portfolio in Q2 2016.
- Strategic Advisors opened 6 new positions and closed 19 in Q2 2016.
- Strategic Advisors's portfolio value fell 1.4% quarter-over-quarter to $173M.
Based on Strategic Advisors's 13F filing for Q2 2016, filed 19 Jul 2016.